XORTX Therapeutics (XRTX) Interest Expenses (2020 - 2023)
XORTX Therapeutics' (XRTX) quarterly Interest Expenses came in at $1379.0 in Q1 2023, down 47.92% YoY from $2647.9 in Q1 2022, and down 97.43% on a QoQ basis from $53723.3 in Q4 2022.
XORTX Therapeutics (XRTX) Interest Expenses (2020 - 2023) Analysis & Trends
XORTX Therapeutics (XRTX) has 4 years of Interest Expenses data on file, last reported at $1379.0 in Q1 2023.
- Quarterly Interest Expenses fell 47.92% year-over-year to $1379.0 in Q1 2023, while the trailing twelve-month figure through Dec 2023 was $1379.0 (down 98.67% YoY) and the FY2025 annual result came in at $41870.0, down 65.65% from the prior year.
- Interest Expenses eased to $1379.0 in Q1 2023, from $53723.3 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $53723.3 in Q4 2022 to a low of -$1487.0 in Q1 2021.
- A 4-year average of $9028.1 and a median of -$541.0 in 2021 frame the typical range for Interest Expenses.
- Annual changes were most pronounced in 2021 — Interest Expenses tumbled 111.8% — and 2022, when it jumped 4157.41%.
- Tracing XRTX's Interest Expenses over 4 years: stood at -$625.15 in 2020, then plunged by 111.8% to -$1324.1 in 2021, then jumped by 4157.41% to $53723.3 in 2022, then slumped by 97.43% to $1379.0 in 2023.
- The last three Interest Expenses figures came in at $1379.0 (Q1 2023), $53723.3 (Q4 2022), and $35485.0 (Q3 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 39.74 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 82.05 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 20.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 93.62 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -4.89 Mn |
| 10 | XORTX Therapeutics | 2.78 Mn | 2.78 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -186,236.34 |
| Dec 31, 2023 | -186,236.34 |
| Mar 31, 2023 | 1,379.00 |
| Mar 31, 2023 | 1,379.00 |
| Dec 31, 2022 | 53,723.33 |
| Dec 31, 2022 | 53,723.33 |
| Sep 30, 2022 | 35,485.02 |
| Sep 30, 2022 | 35,485.02 |
| Jun 30, 2022 | 11,778.44 |
| Jun 30, 2022 | 11,778.44 |
| Mar 31, 2022 | 2,647.90 |
| Mar 31, 2022 | 2,647.90 |
| Dec 31, 2021 | -1,324.08 |
| Dec 31, 2021 | -1,324.08 |
| Sep 30, 2021 | -1,097.87 |
| Sep 30, 2021 | -1,097.87 |
| Jun 30, 2021 | -541.00 |
| Jun 30, 2021 | -541.00 |
| Mar 31, 2021 | -1,486.97 |
| Mar 31, 2021 | -1,486.97 |